WHAT WE DO
We’re working hard to improve survival and treatments for young adult cancer patients.
WE FUND GROUNDBREAKING RESEARCH
What type of research does the Rutledge Foundation support?
Translational research applies findings from basic science to enhance human health and well-being. In a medical research context, it aims to “translate” findings in fundamental research into medical practice and meaningful health outcomes.
The Rutledge Foundation’s mission is to fund translational research that has been proven in the lab and is moving toward clinical trials that show promise for new, less toxic, more curative cancer therapies, quickly and safely.
At a glance
Read about the latest research here.
Rutledge Foundation Grants $55,000 To Continue Work On Less Toxic Nanoparticle Drug Delivery For Pediatric Sarcomas
In March, Rutledge Foundation granted $55,000 to help continue Dr. Andras Lacko’s work on a Lipoprotein Delivery System for pediatric cancers at UNT Health Science Center. This new nanoparticle delivery system hopes to minimize the short and long term side effects of otherwise toxic chemotherapies and other targeted therapies. A collaboration between UNTHSC and Texas Children’s Hospital, initiated by the Rutledge Foundation, is underway +
It has been the hope of the Rutledge Foundation since its inception, to help provide cutting edge clinical trials to +
The Nathalie Traller family established a fund with the Rutledge Foundation to honor Nathalie and her goal to find a +
On April 10, 2015, the Rutledge Foundation presented Dr. Andras Lacko and his team of researchers at UNT Health Science +
WE FUND CLINICAL TRIALS
What is a Clinical Trial?
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. These studies also may show which medical approaches work best for certain illnesses or groups of people. Clinical trials produce the best data available for health care decisionmaking. National Institute of Health
For some patients, clinical research trials represent an avenue for receiving promising new therapies that would not otherwise be available. Patients with difficult to treat or currently “incurable” diseases, such as AIDS or certain types of cancer, may want to pursue participation in clinical research trials if standard therapies are not effective. Clinical research trials are sometimes lifesaving. Medicinenet.com
We fund clinical trials that show promise for new sarcoma treatments. Orphan cancers like pediatric sarcomas don’t require the larger population of patients and can achieve “Orphan Drug’ status with the FDA which will help streamline the arduous efficacy and safety studies that are required.
Learn how we’re supporting clinical trials below.
VIGIL is the first immunotherapy trial designed specifically for Ewing sarcoma patients. A new cohort to the EWING VIGIL VACCINE +
Targeted Clinical Trial for Ewing Sarcoma Now Open DALLAS, December 5, 2016– Mary Crowley Cancer Research has opened a new +